Assess inhibition activity of 2 test articles (TA) for general efflux and uptake transporters
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00584
- Awardee
-
Xenobiotic Laboratories Inc. UEI K254CMCPAFJ8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $134,500
Award facts
- Opportunity
-
- Assess inhibition activity of 2 test articles (TA) for general Efflux and Uptake Transporters Pre-Solicitation · 75N95023Q00357 · Posted May 12, 2023
- Contract value 100% obligated
- $134,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $134,500 firm fixed price purchase order to Xenobiotic Laboratories Inc. Biotesting Division for assessment of inhibition activity and substrate potential of two test articles for major human drug transporters. The solicitation requested the prime contractor evaluate Mitragynine and its metabolite 7-hydroxymitragynine to support drug development, using study designs compliant with FDA recommendations as outlined in the statement of work. Performance will take place in Bethesda, Maryland from September 2023 through January 2024. The award was made on a competitive basis under simplified acquisition procedures to the offeror whose response was most advantageous based on technical capability, price, and past performance. No subcontractors or set-aside designations were identified.
Quick answers
Who was awarded contract 75N95023P00584?
75N95023P00584 was awarded to Xenobiotic Laboratories Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2023.
How much is contract 75N95023P00584 worth?
The government has obligated $134,500 on 75N95023P00584.
Which agency awarded contract 75N95023P00584?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00584, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00584 competed?
The extent of competition for 75N95023P00584 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award